Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study. - Vose JM; Ganguly S; Bierman PJ; Bociek RG; Lunning M; Lyden L; Meza JL; Caimi PF; Armitage JO (British journal of haematology, 2023)